ARWR
Price
$13.25
Change
+$0.19 (+1.45%)
Updated
May 8 closing price
Capitalization
1.79B
3 days until earnings call
ZNTL
Price
$1.26
Change
+$0.03 (+2.44%)
Updated
May 8 closing price
Capitalization
90.66M
90 days until earnings call
Ad is loading...

ARWR vs ZNTL

Header iconARWR vs ZNTL Comparison
Open Charts ARWR vs ZNTLBanner chart's image
Arrowhead Pharmaceuticals
Price$13.25
Change+$0.19 (+1.45%)
Volume$1.29M
Capitalization1.79B
Zentalis Pharmaceuticals
Price$1.26
Change+$0.03 (+2.44%)
Volume$911.95K
Capitalization90.66M
ARWR vs ZNTL Comparison Chart
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARWR vs. ZNTL commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a Hold and ZNTL is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (ARWR: $13.25 vs. ZNTL: $1.26)
Brand notoriety: ARWR: Notable vs. ZNTL: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 72% vs. ZNTL: 108%
Market capitalization -- ARWR: $1.79B vs. ZNTL: $90.66M
ARWR [@Biotechnology] is valued at $1.79B. ZNTL’s [@Biotechnology] market capitalization is $90.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, both ARWR and ZNTL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 6 TA indicator(s) are bullish while ZNTL’s TA Score has 4 bullish TA indicator(s).

  • ARWR’s TA Score: 6 bullish, 2 bearish.
  • ZNTL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ARWR is a better buy in the short-term than ZNTL.

Price Growth

ARWR (@Biotechnology) experienced а -5.63% price change this week, while ZNTL (@Biotechnology) price change was -13.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

ARWR is expected to report earnings on Aug 11, 2025.

ZNTL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($1.79B) has a higher market cap than ZNTL($90.7M). ARWR YTD gains are higher at: -29.521 vs. ZNTL (-58.416). ZNTL has higher annual earnings (EBITDA): -207.96M vs. ARWR (-580.69M). ARWR has more cash in the bank: 553M vs. ZNTL (391M). ZNTL has less debt than ARWR: ZNTL (40.5M) vs ARWR (525M). ZNTL has higher revenues than ARWR: ZNTL (40.6M) vs ARWR (2.5M).
ARWRZNTLARWR / ZNTL
Capitalization1.79B90.7M1,977%
EBITDA-580.69M-207.96M279%
Gain YTD-29.521-58.41651%
P/E RatioN/AN/A-
Revenue2.5M40.6M6%
Total Cash553M391M141%
Total Debt525M40.5M1,296%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARWRZNTL
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APTOF1.650.10
+6.45%
Aptose Biosciences Inc
SLLDY9.540.21
+2.25%
Sanlam Ltd.
RBGLY13.04-0.28
-2.10%
Reckitt Benckiser Group Plc.
FTCO3.13-0.07
-2.19%
Fortitude Gold Corporation
AHCHY13.23-0.48
-3.53%
Anhui Conch Cement Co., Ltd.

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with DNLI. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
+1.45%
DNLI - ARWR
56%
Loosely correlated
+0.77%
RGNX - ARWR
54%
Loosely correlated
-1.24%
NTLA - ARWR
54%
Loosely correlated
+13.58%
BEAM - ARWR
52%
Loosely correlated
+6.32%
VERV - ARWR
50%
Loosely correlated
+6.16%
More